BAP updated guidelines: evidence-based guidelines for the pharmacological management of substance abuse, harmful use, addiction and comorbidity: recommendations from BAP
Open Access
- 23 May 2012
- journal article
- research article
- Published by SAGE Publications in Journal of Psychopharmacology
- Vol. 26 (7), 899-952
- https://doi.org/10.1177/0269881112444324
Abstract
The British Association for Psychopharmacology guidelines for the treatment of substance abuse, harmful use, addiction and comorbidity with psychiatric disorders primarily focus on their pharmacological management. They are based explicitly on the available evidence and presented as recommendations to aid clinical decision making for practitioners alongside a detailed review of the evidence. A consensus meeting, involving experts in the treatment of these disorders, reviewed key areas and considered the strength of the evidence and clinical implications. The guidelines were drawn up after feedback from participants. The guidelines primarily cover the pharmacological management of withdrawal, short- and long-term substitution, maintenance of abstinence and prevention of complications, where appropriate, for substance abuse or harmful use or addiction as well management in pregnancy, comorbidity with psychiatric disorders and in younger and older people.Keywords
This publication has 543 references indexed in Scilit:
- Smoking Cessation Interventions for Patients with Depression: A Systematic Review and Meta-analysisJournal of General Internal Medicine, 2011
- Nicotine receptor partial agonists for smoking cessationPublished by Wiley ,2011
- Effect of Acamprosate on Magnetic Resonance Spectroscopy Measures of Central Glutamate in Detoxified Alcohol-Dependent IndividualsArchives of General Psychiatry, 2010
- Effects of baclofen and mirtazapine on a laboratory model of marijuana withdrawal and relapsePsychopharmacology, 2010
- Cocaine Vaccine for the Treatment of Cocaine Dependence in Methadone-Maintained PatientsArchives of General Psychiatry, 2009
- Extended vs Short-term Buprenorphine-Naloxone for Treatment of Opioid-Addicted YouthJama-Journal Of The American Medical Association, 2008
- Predicting response to opiate antagonists and placebo in the treatment of pathological gamblingPsychopharmacology, 2008
- Baclofen and Gamma-Hydroxybutyrate WithdrawalNeurocritical Care, 2008
- An Evaluation of μ-Opioid Receptor (OPRM1) as a Predictor of Naltrexone Response in the Treatment of Alcohol DependenceArchives of General Psychiatry, 2008
- Effects of THC and lofexidine in a human laboratory model of marijuana withdrawal and relapsePsychopharmacology, 2007